Cargando…

Quality of INR control and switching to non-Vitamin K oral anticoagulants between women and men with atrial fibrillation treated with Vitamin K Antagonists in Spain. A population-based, real-world study

BACKGROUND: Worldwide, there is growing evidence that quality of international normalized ratio (INR) control in atrial fibrillation patients treated with Vitamin K Antagonists (VKA) is suboptimal. However, sex disparities in population-based real-world settings have been scarcely studied, as well a...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Sempere, Aníbal, Hurtado, Isabel, Bejarano-Quisoboni, Daniel, Rodríguez-Bernal, Clara, Santa-Ana, Yared, Peiró, Salvador, Sanfélix-Gimeno, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372152/ https://www.ncbi.nlm.nih.gov/pubmed/30753227 http://dx.doi.org/10.1371/journal.pone.0211681

Ejemplares similares

Group-based Trajectory Models to Assess Quality of INR Control and Its Association With Clinical Outcomes
por: García-Sempere, Aníbal, et al.
Publicado: (2020)

Association of Vitamin K and Non‐Vitamin K Oral Anticoagulant Use and Cancer Incidence in Atrial Fibrillation Patients
por: Iftimi, Adina A., et al.
Publicado: (2021)

Clinical outcomes of nonvitamin K oral anticoagulants and acenocoumarol for stroke prevention in contemporary practice: A population‐based propensity‐weighted cohort study
por: Rodríguez‐Bernal, Clara L., et al.
Publicado: (2020)

Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2018)

A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region
por: García-Sempere, Aníbal, et al.
Publicado: (2017)

Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis
por: Rodríguez-Bernal, Clara L, et al.
Publicado: (2018)

Assessing Concurrent Adherence to Combined Essential Medication and Clinical Outcomes in Patients With Acute Coronary Syndrome. A Population-Based, Real-World Study Using Group-Based Trajectory Models
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2022)

Predictive Performance of the FRAX Tool Calibrated for Spain vs. an Age and Sex Model: Prospective Cohort Study with 9082 Women and Men Followed for up to 8 Years
por: García-Sempere, Aníbal, et al.
Publicado: (2022)

Trends and Geographical Variability in Osteoporosis Treatment After Hip Fracture: A Multilevel Analysis of 30,965 Patients in the Region of Valencia, Spain
por: Hurtado, Isabel, et al.
Publicado: (2020)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Primary Nonadherence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodriguez-Bernal, Clara L., et al.
Publicado: (2018)

Increasing Trends in Opioid Use From 2010 to 2018 in the Region of Valencia, Spain: A Real-World, Population-Based Study
por: Hurtado, Isabel, et al.
Publicado: (2020)

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015
por: Hurtado-Navarro, Isabel, et al.
Publicado: (2019)

Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study
por: García-Sempere, Aníbal, et al.
Publicado: (2017)

INR and vitamin K–dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma
por: Hood, Christopher, et al.
Publicado: (2022)

Incidence of Subsequent Hip Fracture and Mortality in Elderly Patients: A Multistate Population‐Based Cohort Study in Eastern Spain
por: Llopis‐Cardona, Fran, et al.
Publicado: (2022)

Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2021)

Real-world patterns of opioid therapy initiation in Spain, 2012–2018: A population-based, retrospective cohort study with 957,080 patients and 1,509,488 initiations
por: Hurtado, Isabel, et al.
Publicado: (2022)

Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2018)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences
por: Schein, Jeff R., et al.
Publicado: (2016)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

Cost‐Sharing Increase, Medication Adherence, and Hospitalizations in Schizophrenia Patients: A Natural Experiment
por: Serra‐Burriel, Miquel, et al.
Publicado: (2021)

Overuse and Underuse of Antiosteoporotic Treatments According to Highly Influential Osteoporosis Guidelines: A Population-Based Cross-Sectional Study in Spain
por: Sanfélix-Gimeno, Gabriel, et al.
Publicado: (2015)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
por: Mujer, Mark Terence P., et al.
Publicado: (2020)

Adherence to oral anticoagulants in patients with atrial fibrillation—a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol
por: Sanfélix-Gimeno, G, et al.
Publicado: (2015)

Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery
por: Manfredini, Mattia, et al.
Publicado: (2021)

Real-World Patterns of Pharmacotherapeutic Management of Asthma Patients With Exacerbations in the Spanish National Health System
por: Hurtado, Isabel, et al.
Publicado: (2020)

Impact of osteoporosis and vertebral fractures on quality-of-life. a population-based study in Valencia, Spain (The FRAVO Study)
por: Sanfélix-Genovés, José, et al.
Publicado: (2011)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends
por: Shiyovich, Arthur, et al.
Publicado: (2021)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
por: Camilleri, Eleonora, et al.
Publicado: (2021)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns
por: Toorop, Myrthe M. A., et al.
Publicado: (2020)

Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters
por: Rodríguez-Olleros Rodríguez, Celia, et al.
Publicado: (2019)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lotplsh78dtp8tdpe79m58j04p